Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
Emergent BioSolutions(EBS) Newsfilter·2024-01-11 21:00Emergent BioSolutions Inc. - Emergent BioSolutions Inc.宣布与美国国防部签订了一份总值高达2.358亿美元的无限制交付合同[1] - BioThrax®（炭疽疫苗吸附）被用于美国军队的预防性预防措施[3] - Emergent BioSolutions的使命是保护和增强生命，提供针对公共卫生威胁的解决方案[6]